The nation of Zimbabwe has rejected a significant US healthcare agreement worth 367 million US dollars (272 million pounds) spanning five years over Washington's demand for sensitive data.
This move came to light following a official document dated December was disclosed, which showed President Emmerson Mnangagwa deemed the agreement was "lopsided".
An official spokesperson has since stated that the United States was requesting genetic material for scientific study and commercial purposes while was unwilling to guarantee the resulting advantages from any future treatments.
"We will now turn to the challenging and unfortunate task of scaling back our support in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont publicly.
Her embassy said the United States had donated over $1.9bn for health programmes to Zimbabwe during the past twenty years.
A medical body in Zimbabwe has called for continued talks to reach a agreement agreeable to all parties so the nation's vital HIV programme can be sustained.
Broader Context
Zimbabwe's decision comes after a similar case in neighbouring Kenya, where a court blocked a similar deal with the US after legal challenges were raised about the safety of citizens' medical information.
After resuming the presidency recently, US President Donald Trump has reduced foreign aid and shut down the key foreign aid agency.
The agency had administered aid for the US government, but Trump claimed its spending was "wasteful" and his administration was pursuing government-to-government deals to enhance openness and responsibility.
As per reports, 16 African countries have so far agreed to these new health pacts, representing over $18.3bn in new funding.
Specifics of the Rejected Deal
The funds for Zimbabwe was intended to funded "tackling HIV/Aids, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.
"We are confident this cooperation could have provided significant benefits for the people of Zimbabwe, especially the 1.2 million men, women and children currently receiving antiretroviral therapy via American-funded initiatives," the Ambassador commented.
However, government spokesperson Nick Mangwana maintained the proposed deal was "unfair".
"The proposal required Zimbabwe to surrender its biological resources and data indefinitely, without any equivalent assurance of benefiting from any scientific breakthroughs – like new medicines or tests – that could be developed from that provided information," his statement read.
"Put simply, our country would provide the basic resources for scientific discovery without any assurance that the final treatments would be available to our citizens if a new health crisis arise."
Sovereignty and Global Health
He also pointed out that the American exit from the global health body and its pursuit of bilateral health agreements were disrupting structures already set up through the international health agency.
The spokesperson gave as an example its Pathogen Access and Benefit Sharing scheme designed to manage potential global health emergencies.
"This system is designed to ensure that when a nation provides its samples, the benefits – such as medicines and cures – are shared equitably, not commercialised solely by those with the capability to create them."
The government's concerns regarding the US deal "must not be interpreted as anti-American sentiment," Mangwana stressed.
"We are open to further dialogue with our American counterparts on how future co-operation could be designed in a manner that honours the sovereignty and interests of each country."
Medical Community Response
The Zimbabwe College of Public Health Physicians (ZCPHP) said it recognised the government's concerns, but urged that talks need to persist since a large portion of the nation's Aids initiatives were funded by external financing.
"In cases where specific concerns arise, including those relating to data governance or agreement terms, these can frequently be addressed through technical clarification and mutually agreed protections," the group added.
The halted deal highlights the ongoing tensions between receiving vital foreign assistance and protecting national sovereignty in an ever more interconnected world.